Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

If you struggle with persistent dandruff, Dr. Ziering says you may benefit from a scalp detox routine. Specifically, he ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...